OBTAIN: A study of the occurrence of bleeding and thrombosis during anti-platelet therapy in non-cardiac surgery

European Journal of Anaesthesiology

Volumn 28, Issue 6, 2011, Pages 456-459

  Howell, Simon J ^a,e   Hoeks, Sanne E ^b   Poldermans, Don ^b   West, Robert M ^c   Wheatcroft, Tephen B ^d  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c Centre of Epidemiology and Biostatistics   (United Kingdom)

^d UNIVERSITY OF LEEDS   (United Kingdom)

^e ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLOPIDOGREL;

ARTICLE; BARE METAL STENT; BLEEDING; DRUG ELUTING STENT; HEART INFARCTION; HEART SURGERY; HUMAN; MAJOR CLINICAL STUDY; PERCUTANEOUS CORONARY INTERVENTION; REOPERATION; STENT THROMBOSIS;

ANESTHESIOLOGY; HUMANS; RESEARCH DESIGN;

EID: 79959693321     PISSN: 02650215     EISSN: 13652346     Source Type: Journal    
DOI: 10.1097/EJA.0b013e328344b4fc     Document Type: Article

References (11)

1. Wenaweser P, Daemen J, Zwahlen M, et al. Incidence and correlates of drug-eluting stent thrombosis in routine clinical practice: 4-year results from a large 2-institutional cohort study. J Am Coll Cardiol 2008; 52:1134-1140.
2. Mauri L, Hsieh W-H, Massaro JM, et al. Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007; 356:1020-1029. (Pubitemid 46376802)
3. King SB 3rd, Smith SC Jr, Hirshfeld JW Jr, et al. 2007 focused update of the ACC/AHA/SCAI 2005 guideline update for percutaneous coronary intervention: a report of the American College of Cardiology/American Heart Association Task Force on Practice guidelines. J Am Coll Cardiol 2008; 51:172-209.
4. Poldermans D, Bax JJ, Boersma E, et al. Guidelines for preoperative cardiac risk assessment and perioperative cardiac management in noncardiac surgery: the Task Force for Preoperative Cardiac Risk Assessment and Perioperative Cardiac Management in Noncardiac Surgery of the European Society of Cardiology (ESC) and endorsed by the European Society of Anaesthesiology (ESA). Eur J Anaesthesiol 2010; 27:92-137.
5. Burger W, Chemnitius JM, Kneissl GD, Rucker G. Low-dose aspirin for secondary cardiovascular prevention: cardiovascular risks after its perioperative withdrawal versus bleeding risks with its continuation -review and meta-analysis. J Inter Med 2005; 257:399-414. (Pubitemid 40604544)
6. Oscarsson A, Gupta A, Fredrikson M, et al. To continue or discontinue aspirin in the perioperative period: a randomized, controlled clinical trial. Br J Anaesth 2010; 104:305-312.
7. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology 2008; 109:596-604.
8. Bowry AD, Brookhart MA, Choudhry NK. Meta-analysis of the efficacy and safety of clopidogrel plus aspirin as compared to antiplatelet monotherapy for the prevention of vascular events. Am J Cardiol 2008; 101:960-966.
9. Kaluza GL, Joseph J, Lee JR, et al. Catastrophic outcomes of noncardiac surgery soon after coronary stenting. J Am Coll Cardiol 2000; 35:1288-1294. (Pubitemid 30206904)
10. Thygesen K, Alpert JS, White HD, et al. Universal definition of myocardial infarction. Circulation 2007; 116:2634-2653. (Pubitemid 350182388)
11. Kapetanakis EI, Medlam DA, Boyce SW, et al. Clopidogrel administration prior to coronary artery bypass grafting surgery: the cardiologist's panacea or the surgeon's headache? Eur Heart J 2005; 26:576-583. (Pubitemid 40461099)